Citrus Sinensis ID: 006842

Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------63
MGSTSTISLYSHPKLSHRAQPVLSRSFCQARDAPLSFALPFSGTRRCFRLKRLVVKAAARPEGGRRQRRVYRQSQSDNALTTAPVKQIASFVVPAGVFVSATFVLWKLVEKLLMPKPSRPSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEVCSGCNGLSFFHSAIYSLKHMLFYSLCINYLQGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
ccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccHHHHHHHHHHHHccccccccccHHHHHccccccHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHcccccEEEcccccccHHHHHHHHHHHHHcccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHHcccccEEEcccccccHHHHHHHHHHHcccccccEEEEEcccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHccccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHcccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHccccccccEEEcccccccHHHHHHHHHHHHHcccccEEEEEEEcccccHHHHHHHHHHHHHccccccEEEEEEc
cccccEEEEcccccccccccHHHccccccccccccccccccEccccccccccEEEEEccccccccHHHHHHHHHHHHcccccccHHEEEEEccccccHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHcHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccccEEEcccccccHHHHHHHHHHHccccccEEEEcccccccHHHHHHHHHHHHHcccccEEEccccccHHHHHHHHHHHHHccccEEEEEEccccccHHHHHHHHHHHHHcccccEEEcccccccHHHHHHHHHHHHcccccEEEEEccccccHHHHHHHHHHHHHcccccEEEccccccHHHHHHHHHHHHccccccccEEEcccccccHHHHHHHHHHHHHcccccEEEccccccHHHHHHHHHHHHHcccccEEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHccccccEEEEcccccccHHHHHHHHHHHHHcccccEEEccccccccHHHHHHHHHHHHHHccccccHHHEEccccccHHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHcccccEEEEEEcccccccHHHHHHHHHHHHHcccccEEEEEEEc
mgststislyshpklshraqpvlsrsfcqardaplsfalpfsgtrrcfRLKRLVVKAaarpeggrrqrRVYRqsqsdnalttapvkQIASFVVPAGVFVSATFVLWKLVEKllmpkpsrpskptaegmnwsvgagtnllsgftgKLFRESKQTLNEFAKELRAFSsvdmsgrnfgdeGLFFLAESlgynqtaeevsfAANGITAAGIKAFDGVLQSNIALktlnlsgnpigdegVKCLCDILvdnagverlqlssVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTirslhlngnyggaLGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDignnsisakGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQnrtittidlggnnihskGASAIARVLkdnsvitsldlaynpigaDGAKALSEVLKFHGnintlklgwcqigaSGAEFVADMLRYNNTISILDLRAnglrdevcsgcnglsFFHSAIYSLKHMLFYSLCINYLQGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
mgststislyshpklshrAQPVLSRSFCQARDAPLsfalpfsgtrrcfRLKRLvvkaaarpeggrrqrrvyrqsqsdnalttapvKQIASFVVPAGVFVSATFVLWKLVEKLLMPKPSRPSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTIttidlggnnihSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEVCSGCNGLSFFHSAIYSLKHMLFYSLCINYLQGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
MGSTSTISLYSHPKLSHRAQPVLSRSFCQARDAPLSFALPFSGTRRCFRLKRLVVKAAARPEGGrrqrrvyrqsqsDNALTTAPVKQIASFVVPAGVFVSATFVLWKLVEKLLMPKPSRPSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHlngnyggalganalakglegnKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEVCSGCNGLSFFHSAIYSLKHMLFYSLCINYLQGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
************************RSFCQARDAPLSFALPFSGTRRCFRLKRLVVKAA**********************TTAPVKQIASFVVPAGVFVSATFVLWKLVEKLL***************NWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEVCSGCNGLSFFHSAIYSLKHMLFYSLCINYLQGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYE**********
*******************************DAPLSFALPFSGTRRCFRLKR*******************************PVKQIASFVVPAGVFVSATFVLWKLVE*******************WSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEVCSGCNGLSFFHSAIYSLKHMLFYSLCINYLQGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
********LYSHPKLSHRAQPVLSRSFCQARDAPLSFALPFSGTRRCFRLKRLVVKAAA*********************TTAPVKQIASFVVPAGVFVSATFVLWKLVEKLLMPKP********EGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEVCSGCNGLSFFHSAIYSLKHMLFYSLCINYLQGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
****STISLYSHPKLSHRAQPVLSRSFCQARDAPLSFALPFSGTRRCFRLKRLVVKAAARPEGGRRQRRVYRQSQSDNALTTAPVKQIASFVVPAGVFVSATFVLWKLVEKLLMPKPSRPSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEVCSGCNGLSFFHSAIYSLKHMLFYSLCINYLQGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MGSTSTISLYSHPKLSHRAQPVLSRSFCQARDAPLSFALPFSGTRRCFRLKRLVVKAAARPEGGRRQRRVYRQSQSDNALTTAPVKQIASFVVPAGVFVSATFVLWKLVEKLLMPKPSRPSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEVCSGCNGLSFFHSAIYSLKHMLFYSLCINYLQGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

Original result of BLAST against SWISS-PROT Database

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query629 2.2.26 [Sep-21-2011]
Q7RTR21065 Protein NLRC3 OS=Homo sap yes no 0.696 0.411 0.345 2e-49
Q5DU561064 Protein NLRC3 OS=Mus musc yes no 0.686 0.406 0.321 5e-44
P29315456 Ribonuclease inhibitor OS yes no 0.556 0.767 0.271 5e-26
P10775456 Ribonuclease inhibitor OS no no 0.492 0.679 0.303 6e-26
Q91VI7456 Ribonuclease inhibitor OS no no 0.589 0.813 0.265 1e-25
Q647I91098 NACHT, LRR and PYD domain no no 0.546 0.313 0.281 2e-25
Q9LE82535 RAN GTPase-activating pro no no 0.589 0.693 0.262 2e-23
Q0VAA2488 Uncharacterized protein C no no 0.386 0.497 0.310 5e-22
P13489461 Ribonuclease inhibitor OS no no 0.658 0.898 0.257 9e-22
Q9Y239953 Nucleotide-binding oligom no no 0.311 0.205 0.335 1e-21
>sp|Q7RTR2|NLRC3_HUMAN Protein NLRC3 OS=Homo sapiens GN=NLRC3 PE=2 SV=2 Back     alignment and function desciption
 Score =  197 bits (502), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 155/449 (34%), Positives = 231/449 (51%), Gaps = 11/449 (2%)

Query: 150  SKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESL-GYNQTAEEVSFAANGITAAGIK 208
            S+  L     +L     + +    F D  +  L   L G +   +++S A N I+  G K
Sbjct: 625  SQGVLQSLLPQLLYCRKLRLDTNQFQDPVMELLGSVLSGKDCRIQKISLAENQISNKGAK 684

Query: 209  AFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAE 268
            A    L  N +L +L+L GN IG +G K L D L  N  +  L L    +RD+GA+++AE
Sbjct: 685  ALARSLLVNRSLTSLDLRGNSIGPQGAKALADALKINRTLTSLSLQGNTVRDDGARSMAE 744

Query: 269  LLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEG 328
             L +N  L +L L  N I   G   +A+AL +N +++ L  + N  G  GA ALA+ L+ 
Sbjct: 745  ALASNRTLSMLHLQKNSIGPMGAQRMADALKQNRSLKELMFSSNSIGDGGAKALAEALKV 804

Query: 329  NKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKS 388
            N+ L  L L  NSI D G+ ALM  L + +  L+ L +  NSIS +GA  +A  +    +
Sbjct: 805  NQGLESLDLQSNSISDAGVAALMGALCTNQTLLS-LSLRENSISPEGAQAIAHALCANST 863

Query: 389  LLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSL 448
            L  ++L  N + D+GA  IA A+++NRT+T++ L  N I +  A A+ + L+ N  +TSL
Sbjct: 864  LKNLDLTANLLHDQGARAIAVAVRENRTLTSLHLQWNFIQAGAAQALGQALQLNRSLTSL 923

Query: 449  DLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRA 508
            DL  N IG DGA A++  LK +  +  L L    IGASGA+ + + L  N T+ ILDLR 
Sbjct: 924  DLQENAIGDDGACAVARALKVNTALTALYLQVASIGASGAQVLGEALAVNRTLEILDLRG 983

Query: 509  NGLRDEVCSGCNGLSFFHSAIYSLKHMLFYSLCINYL--QGAKCLAQSFKVVNEALTSID 566
            N +      G  G     +A+     +   +L  N L   GA C+A +    N  L  I+
Sbjct: 984  NAI------GVAGAKALANALKVNSSLRRLNLQENSLGMDGAICIATALS-GNHRLQHIN 1036

Query: 567  LAFNEIRDDGAFAIAQALKANEDVAVTSL 595
            L  N I D GA  I++A+K N       +
Sbjct: 1037 LQGNHIGDSGARMISEAIKTNAPTCTVEM 1065
May modulate T-cell activation. Decreases the transcription of genes that are normally up-regulated after T-cell stimulation. Delays degradation of NFKBIA/IKBA.
Homo sapiens (taxid: 9606)
>sp|Q5DU56|NLRC3_MOUSE Protein NLRC3 OS=Mus musculus GN=Nlrc3 PE=2 SV=2 Back     alignment and function description
>sp|P29315|RINI_RAT Ribonuclease inhibitor OS=Rattus norvegicus GN=Rnh1 PE=1 SV=2 Back     alignment and function description
>sp|P10775|RINI_PIG Ribonuclease inhibitor OS=Sus scrofa GN=RNH1 PE=1 SV=1 Back     alignment and function description
>sp|Q91VI7|RINI_MOUSE Ribonuclease inhibitor OS=Mus musculus GN=Rnh1 PE=1 SV=1 Back     alignment and function description
>sp|Q647I9|NALP5_BOVIN NACHT, LRR and PYD domains-containing protein 5 OS=Bos taurus GN=NLRP5 PE=2 SV=1 Back     alignment and function description
>sp|Q9LE82|RAGP1_ARATH RAN GTPase-activating protein 1 OS=Arabidopsis thaliana GN=RANGAP1 PE=1 SV=1 Back     alignment and function description
>sp|Q0VAA2|CN16B_HUMAN Uncharacterized protein C14orf166B OS=Homo sapiens GN=C14orf166B PE=2 SV=2 Back     alignment and function description
>sp|P13489|RINI_HUMAN Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 Back     alignment and function description
>sp|Q9Y239|NOD1_HUMAN Nucleotide-binding oligomerization domain-containing protein 1 OS=Homo sapiens GN=NOD1 PE=1 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

Original result of BLAST against Nonredundant Database

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query629
296086512630 unnamed protein product [Vitis vinifera] 0.937 0.936 0.678 0.0
255558382607 leucine rich repeat-containing protein, 0.937 0.971 0.682 0.0
359473416684 PREDICTED: protein NLRC3-like [Vitis vin 0.918 0.845 0.696 0.0
356501981606 PREDICTED: protein NLRC3-like [Glycine m 0.947 0.983 0.674 0.0
357486129606 Nucleotide-binding oligomerization domai 0.942 0.978 0.671 0.0
297843864605 EMB2004 [Arabidopsis lyrata subsp. lyrat 0.942 0.980 0.675 0.0
18391166605 leucine-rich repeats-ribonuclease inhibi 0.942 0.980 0.675 0.0
356498020606 PREDICTED: protein NLRC3-like [Glycine m 0.947 0.983 0.665 0.0
258678027614 chloroplast envelope protein 1 [Nicotian 0.945 0.969 0.641 0.0
449452044602 PREDICTED: LOW QUALITY PROTEIN: protein 0.937 0.980 0.647 0.0
>gi|296086512|emb|CBI32101.3| unnamed protein product [Vitis vinifera] Back     alignment and taxonomy information
 Score =  856 bits (2212), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 450/663 (67%), Positives = 507/663 (76%), Gaps = 73/663 (11%)

Query: 3   STSTISLYSHP-------------------KLSHRAQPVLSRS---------FCQARDAP 34
           STS I LYSHP                   ++SHRA+P   RS         +C    A 
Sbjct: 5   STSAICLYSHPMVLSSSSSQSPNLTFCSDSQISHRARPRNLRSQVLGSSWWGYC----AL 60

Query: 35  LSFALPFSGTRRCFRLKRLVVKAAARPEGGRRQ----RRVYRQSQSDNALTTAPVKQIAS 90
           L  ++  S  R  +R + LV  AA+  +G  R+    RRV++QSQ    L+  PV++IAS
Sbjct: 61  LPTSVYVSSIRH-YRFRTLVTVAASTADGVPRRPVSGRRVFKQSQGQGPLSPVPVREIAS 119

Query: 91  FVVPAGVFVSATFVLWKLVEKLLMPKPSRPSKPTA----EGMNWSVGAGTNLLSGFTGKL 146
           FVVPA +F + TFVLW+LVEK+L+PK SR S         G+ WS   GTNLL+G T K 
Sbjct: 120 FVVPASLFFAVTFVLWRLVEKILLPKSSRSSSLEKKSSSPGVKWSFAPGTNLLAGLTAKF 179

Query: 147 FRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAG 206
            RESKQ LNEFAKE+R+F SVDMSGRNFGDEGLFFLAESL YNQ AEEVSFAANGITAAG
Sbjct: 180 DRESKQKLNEFAKEIRSFGSVDMSGRNFGDEGLFFLAESLAYNQNAEEVSFAANGITAAG 239

Query: 207 IKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAI 266
           +KAFDGVLQSNI LKTL+LSGNPIGDEG KCLCDIL+DNAG+++LQL+S DL DEGAKAI
Sbjct: 240 LKAFDGVLQSNIVLKTLDLSGNPIGDEGAKCLCDILIDNAGIQKLQLNSADLGDEGAKAI 299

Query: 267 AELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGL 326
           AE+LK NS LR++ELNNNMIDYSGFTSL  ALLEN+TIR++HLNGNYGGALG  ALAKGL
Sbjct: 300 AEMLKKNSSLRIVELNNNMIDYSGFTSLGGALLENNTIRNIHLNGNYGGALGVAALAKGL 359

Query: 327 EGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNC 386
           E NKSLRELHLHGNSIGDEG+R LMSGLSS KGKL +LDIGNN IS++GAFHVAEYIK  
Sbjct: 360 EANKSLRELHLHGNSIGDEGVRVLMSGLSSHKGKLTLLDIGNNEISSRGAFHVAEYIKKA 419

Query: 387 KSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVIT 446
           KSLLW+NLYMNDIGDEGAEKIADALK+NR+I TIDLGGNNIH+KG S IA VLKDN+VIT
Sbjct: 420 KSLLWLNLYMNDIGDEGAEKIADALKENRSIATIDLGGNNIHAKGVSKIAGVLKDNTVIT 479

Query: 447 SLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDL 506
           +L+L YNPIG +GAKALSEVLKFHG I TLKLGWCQIGA GAEF+AD L+YN TIS LDL
Sbjct: 480 TLELGYNPIGPEGAKALSEVLKFHGKIKTLKLGWCQIGAKGAEFIADTLKYNTTISTLDL 539

Query: 507 RANGLRDEVCSGCNGLSFFHSAIYSLKHMLFYSLCINYLQGAKCLAQSFKVVNEALTSID 566
           RANGLRDE                                GA CLA+S KVVNEAL S+D
Sbjct: 540 RANGLRDE--------------------------------GAVCLARSMKVVNEALASLD 567

Query: 567 LAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVN 626
           L FNEIRD+GAFAIAQALKANEDVAVTSLNLA+NFLTKFGQSALTDA+D VYEMSEKEVN
Sbjct: 568 LGFNEIRDEGAFAIAQALKANEDVAVTSLNLASNFLTKFGQSALTDARDHVYEMSEKEVN 627

Query: 627 IFF 629
           IFF
Sbjct: 628 IFF 630

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota
>gi|255558382|ref|XP_002520218.1| leucine rich repeat-containing protein, putative [Ricinus communis] gi|223540710|gb|EEF42273.1| leucine rich repeat-containing protein, putative [Ricinus communis] Back     alignment and taxonomy information
>gi|359473416|ref|XP_002266381.2| PREDICTED: protein NLRC3-like [Vitis vinifera] Back     alignment and taxonomy information
>gi|356501981|ref|XP_003519801.1| PREDICTED: protein NLRC3-like [Glycine max] Back     alignment and taxonomy information
>gi|357486129|ref|XP_003613352.1| Nucleotide-binding oligomerization domain-containing protein [Medicago truncatula] gi|355514687|gb|AES96310.1| Nucleotide-binding oligomerization domain-containing protein [Medicago truncatula] Back     alignment and taxonomy information
>gi|297843864|ref|XP_002889813.1| EMB2004 [Arabidopsis lyrata subsp. lyrata] gi|297335655|gb|EFH66072.1| EMB2004 [Arabidopsis lyrata subsp. lyrata] Back     alignment and taxonomy information
>gi|18391166|ref|NP_563871.1| leucine-rich repeats-ribonuclease inhibitor domain-containing protein [Arabidopsis thaliana] gi|15810395|gb|AAL07085.1| unknown protein [Arabidopsis thaliana] gi|20258921|gb|AAM14154.1| unknown protein [Arabidopsis thaliana] gi|332190466|gb|AEE28587.1| leucine-rich repeats-ribonuclease inhibitor domain-containing protein [Arabidopsis thaliana] Back     alignment and taxonomy information
>gi|356498020|ref|XP_003517853.1| PREDICTED: protein NLRC3-like [Glycine max] Back     alignment and taxonomy information
>gi|258678027|gb|ACV87735.1| chloroplast envelope protein 1 [Nicotiana benthamiana] Back     alignment and taxonomy information
>gi|449452044|ref|XP_004143770.1| PREDICTED: LOW QUALITY PROTEIN: protein NLRC3-like [Cucumis sativus] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

Original result of BLAST against Gene Ontology (AMIGO)

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query629
TAIR|locus:2194604605 emb2004 "embryo defective 2004 0.907 0.943 0.6 1.9e-170
UNIPROTKB|Q7RTR21065 NLRC3 "Protein NLRC3" [Homo sa 0.686 0.405 0.328 2.2e-48
MGI|MGI:24440701064 Nlrc3 "NLR family, CARD domain 0.686 0.406 0.302 4.7e-42
RGD|621398456 Rnh1 "ribonuclease/angiogenin 0.561 0.774 0.267 4.5e-26
RGD|2321956456 LOC100360501 "ribonuclease inh 0.556 0.767 0.266 8e-26
UNIPROTKB|P10775456 RNH1 "Ribonuclease inhibitor" 0.577 0.796 0.262 1.4e-25
MGI|MGI:1195456456 Rnh1 "ribonuclease/angiogenin 0.550 0.758 0.266 2.6e-25
UNIPROTKB|P13489461 RNH1 "Ribonuclease inhibitor" 0.632 0.863 0.25 9.6e-23
ZFIN|ZDB-GENE-110913-19 1252 si:dkey-156k2.3 "si:dkey-156k2 0.623 0.313 0.256 2.6e-22
UNIPROTKB|Q5ZIY8456 RNH1 "Uncharacterized protein" 0.655 0.903 0.223 6e-22
TAIR|locus:2194604 emb2004 "embryo defective 2004" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
 Score = 1657 (588.4 bits), Expect = 1.9e-170, P = 1.9e-170
 Identities = 357/595 (60%), Positives = 422/595 (70%)

Query:     3 STSTISLYSHPKLSHRAQPVLSRSFCQARDAPLS----FALPFSGTRRCFRLKRLVVKAA 58
             STS+++L+S PK S       S    +   + +S    F  P     R  RL    +KAA
Sbjct:     5 STSSLNLHSLPKASSGLGQWKSGFRYELLGSSVSRNRLFVSPVVIHHRSPRLP--AIKAA 62

Query:    59 ARPEGGXXXXXXXXXXXXDNALTTAPVKQIASFVVPAGVFVSATFVLWKLVEKLLMPKPS 118
                +GG             +    A V+QIAS V+P G F   TFVLWK+V K + PK  
Sbjct:    63 YNSDGGSKRSRVYKESQAASGFPNAKVQQIASSVLPLGSFAVVTFVLWKVVGKFMSPKSP 122

Query:   119 RPS----KPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNF 174
             + S      + +G+ WS+GAGTNLL GF  K+ RE+KQ LNEFAKELR+F SVDMSG NF
Sbjct:   123 KTSAGENNSSTQGVKWSIGAGTNLLQGFAAKVDREAKQRLNEFAKELRSFRSVDMSGCNF 182

Query:   175 GDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEG 234
             GDEGLFFLAESLGYNQT EEVSF+ANGITAAG+KAFDGVLQSNI LK LNLSGNPIGDEG
Sbjct:   183 GDEGLFFLAESLGYNQTVEEVSFSANGITAAGVKAFDGVLQSNIMLKILNLSGNPIGDEG 242

Query:   235 VKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSL 294
              K LC  L++N+ +E LQL+S D+ DEGAK IAELLK NS LR++ELNNNMIDYSGFTSL
Sbjct:   243 AKTLCATLMENSSIEILQLNSTDIGDEGAKEIAELLKRNSTLRIIELNNNMIDYSGFTSL 302

Query:   295 AEALLENSTIRSLHXXXXXXXXXXXXXXXXXXXXXKSLRELHLHGNSIGDEGIRALMSGL 354
             A ALLEN+TIR+LH                     KSLRELHLHGNSIGDEG RALM+GL
Sbjct:   303 AGALLENNTIRNLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGTRALMAGL 362

Query:   355 SSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQN 414
             SS KGK+A+LD+GNNSISAKGAF+VAEYIK  KSL+W+NLYMNDIGDEGAEKIAD+LKQN
Sbjct:   363 SSHKGKVALLDLGNNSISAKGAFYVAEYIKRSKSLVWLNLYMNDIGDEGAEKIADSLKQN 422

Query:   415 RTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNIN 474
             R+I TIDLGGNNIH++G +AIA+ LKDN++IT+L++ YNPIG DGAKALSE+LKFHGN+ 
Sbjct:   423 RSIATIDLGGNNIHAEGVNAIAQALKDNAIITTLEVGYNPIGPDGAKALSEILKFHGNVK 482

Query:   475 TLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEVCSGC--NGLSFFHSAIYSL 532
             TLKLGWCQI A GAE VADMLRYNNTIS+LDLRANGLRDE  S C    L   + A+ S+
Sbjct:   483 TLKLGWCQIAAKGAEHVADMLRYNNTISVLDLRANGLRDEGAS-CLARSLKVVNEALTSV 541

Query:   533 KHMLFYSLCINYLQ--GAKCLAQSFKVVNE--ALTSIDLAFNEIRDDGAFAIAQA 583
                    L  N ++  GA  +AQ+ K  NE   +TSI+L  N I   G  A+  A
Sbjct:   542 ------DLGFNEIRDDGAFAIAQALKA-NEDVTVTSINLGNNFITKFGQSALTDA 589
GO:0005739 "mitochondrion" evidence=ISM;IDA
GO:0009793 "embryo development ending in seed dormancy" evidence=NAS
GO:0009941 "chloroplast envelope" evidence=IDA
GO:0009536 "plastid" evidence=IDA
GO:0009507 "chloroplast" evidence=IDA
UNIPROTKB|Q7RTR2 NLRC3 "Protein NLRC3" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
MGI|MGI:2444070 Nlrc3 "NLR family, CARD domain containing 3" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
RGD|621398 Rnh1 "ribonuclease/angiogenin inhibitor 1" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
RGD|2321956 LOC100360501 "ribonuclease inhibitor-like" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
UNIPROTKB|P10775 RNH1 "Ribonuclease inhibitor" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
MGI|MGI:1195456 Rnh1 "ribonuclease/angiogenin inhibitor 1" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
UNIPROTKB|P13489 RNH1 "Ribonuclease inhibitor" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-110913-19 si:dkey-156k2.3 "si:dkey-156k2.3" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
UNIPROTKB|Q5ZIY8 RNH1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server ?

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Original result from the STRING server

Your Input:
fgenesh2_kg.1__1118__AT1G10510.1
annotation not avaliable (605 aa)
(Arabidopsis lyrata)
Predicted Functional Partners:
 
Sorry, there are no predicted associations at the current settings.
 

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

Original result of RPS-BLAST against CDD database part I

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query629
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 4e-37
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 3e-35
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 2e-29
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 1e-18
COG5238388 COG5238, RNA1, Ran GTPase-activating protein (RanG 2e-07
COG5238388 COG5238, RNA1, Ran GTPase-activating protein (RanG 8e-07
COG5238388 COG5238, RNA1, Ran GTPase-activating protein (RanG 6e-06
smart0036828 smart00368, LRR_RI, Leucine rich repeat, ribonucle 4e-04
>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information 
 Score =  140 bits (355), Expect = 4e-37
 Identities = 85/291 (29%), Positives = 133/291 (45%), Gaps = 32/291 (10%)

Query: 156 EFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAA---------------- 199
           E   +L     + + G   G+E    LA +L    + +E+  +                 
Sbjct: 17  ELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQG 76

Query: 200 --------------NGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDN 245
                         N +   G    + +L+S+ +L+ L L+ N +GD G++ L   L D 
Sbjct: 77  LTKGCGLQELDLSDNALGPDGCGVLESLLRSS-SLQELKLNNNGLGDRGLRLLAKGLKDL 135

Query: 246 A-GVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTI 304
              +E+L L    L     +A+A+ L+ N  L+ L L NN I  +G  +LAE L  N  +
Sbjct: 136 PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNL 195

Query: 305 RSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVL 364
             L LN N     GA+ALA+ L   KSL  L+L  N++ D G  AL S L S    L  L
Sbjct: 196 EVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTL 255

Query: 365 DIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNR 415
            +  N I+  GA  +AE +   +SLL ++L  N  G+EGA+ +A++L +  
Sbjct: 256 SLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPG 306

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319
>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>gnl|CDD|197686 smart00368, LRR_RI, Leucine rich repeat, ribonuclease inhibitor type Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

Original result of HHsearch against CDD database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 629
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 100.0
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 100.0
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 100.0
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 100.0
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.96
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.96
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 99.94
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 99.94
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.93
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.92
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.92
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.91
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.88
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.86
KOG4308478 consensus LRR-containing protein [Function unknown 99.84
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 99.79
KOG4308478 consensus LRR-containing protein [Function unknown 99.78
KOG4237498 consensus Extracellular matrix protein slit, conta 99.77
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 99.74
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 99.73
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 99.73
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 99.7
PLN03210 1153 Resistant to P. syringae 6; Provisional 99.69
KOG4237 498 consensus Extracellular matrix protein slit, conta 99.68
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 99.68
PLN03210 1153 Resistant to P. syringae 6; Provisional 99.64
KOG4341483 consensus F-box protein containing LRR [General fu 99.57
KOG4341483 consensus F-box protein containing LRR [General fu 99.53
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 99.43
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 99.39
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 99.38
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 99.36
KOG0617264 consensus Ras suppressor protein (contains leucine 99.31
KOG0617264 consensus Ras suppressor protein (contains leucine 99.25
KOG1259490 consensus Nischarin, modulator of integrin alpha5 99.07
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 99.06
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 99.03
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.95
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 98.89
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 98.8
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 98.78
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 98.76
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 98.75
KOG0532 722 consensus Leucine-rich repeat (LRR) protein, conta 98.72
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 98.71
KOG0532 722 consensus Leucine-rich repeat (LRR) protein, conta 98.67
KOG2982418 consensus Uncharacterized conserved protein [Funct 98.55
KOG2982418 consensus Uncharacterized conserved protein [Funct 98.53
KOG1947482 consensus Leucine rich repeat proteins, some prote 98.49
KOG1947482 consensus Leucine rich repeat proteins, some prote 98.43
KOG3665 699 consensus ZYG-1-like serine/threonine protein kina 98.41
PLN03150623 hypothetical protein; Provisional 98.4
KOG3665 699 consensus ZYG-1-like serine/threonine protein kina 98.27
PLN03150623 hypothetical protein; Provisional 98.23
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 98.22
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 98.22
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 98.11
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 97.94
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 97.91
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 97.8
KOG2123388 consensus Uncharacterized conserved protein [Funct 97.55
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 97.53
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 97.43
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 97.41
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 97.38
KOG2123388 consensus Uncharacterized conserved protein [Funct 97.25
KOG4242553 consensus Predicted myosin-I-binding protein [Cell 97.0
KOG4242553 consensus Predicted myosin-I-binding protein [Cell 96.94
PRK15386426 type III secretion protein GogB; Provisional 96.58
KOG3735353 consensus Tropomodulin and leiomodulin [Cytoskelet 96.51
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 96.44
KOG3864221 consensus Uncharacterized conserved protein [Funct 96.4
KOG3864221 consensus Uncharacterized conserved protein [Funct 96.33
PRK15386 426 type III secretion protein GogB; Provisional 96.21
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 96.16
smart0036828 LRR_RI Leucine rich repeat, ribonuclease inhibitor 95.62
smart0036828 LRR_RI Leucine rich repeat, ribonuclease inhibitor 95.36
PF1351624 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RI 95.13
KOG3735353 consensus Tropomodulin and leiomodulin [Cytoskelet 95.1
PF1351624 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RI 94.9
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 93.02
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 92.15
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 91.43
smart0036726 LRR_CC Leucine-rich repeat - CC (cysteine-containi 91.32
smart0036726 LRR_CC Leucine-rich repeat - CC (cysteine-containi 90.88
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 89.11
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 87.89
KOG0473 326 consensus Leucine-rich repeat protein [Function un 85.45
smart0036926 LRR_TYP Leucine-rich repeats, typical (most popula 84.79
smart0037026 LRR Leucine-rich repeats, outliers. 84.79
KOG3763 585 consensus mRNA export factor TAP/MEX67 [RNA proces 83.1
KOG3763 585 consensus mRNA export factor TAP/MEX67 [RNA proces 82.63
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information 
Probab=100.00  E-value=2.4e-35  Score=344.76  Aligned_cols=404  Identities=19%  Similarity=0.203  Sum_probs=223.6

Q ss_pred             HHHhcCCccEEEccCCCCCHHHHHHHHHHhccCCCccEEEeccCCCCHHHHHHHHHHhhcCCCcCEEEccCCCCChhHHH
Q 006842          157 FAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVK  236 (629)
Q Consensus       157 ~~~~~~~L~~L~Ls~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~  236 (629)
                      .+..+++|++|+|++|.+...    ++..+..+++|++|+|++|.++..    ++..+..+++|++|+|++|.+...   
T Consensus       159 ~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~---  227 (968)
T PLN00113        159 DIGSFSSLKVLDLGGNVLVGK----IPNSLTNLTSLEFLTLASNQLVGQ----IPRELGQMKSLKWIYLGYNNLSGE---  227 (968)
T ss_pred             HHhcCCCCCEEECccCccccc----CChhhhhCcCCCeeeccCCCCcCc----CChHHcCcCCccEEECcCCccCCc---
Confidence            345566666777766665433    334445556666666666665432    222334556666666666666543   


Q ss_pred             HHHHHHhhCCCCCEEEeeccCCChHHHHHHHHHHhcCCCccEEEeccCCCChhhHHHHHHHHhhcCCccEEeccCCCCCh
Q 006842          237 CLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGA  316 (629)
Q Consensus       237 ~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~  316 (629)
                       ++..+..+++|++|++++|.++..    ++..+.++++|++|++++|.+.+    .++..+..+++|++|++++|.+..
T Consensus       228 -~p~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~n~l~~  298 (968)
T PLN00113        228 -IPYEIGGLTSLNHLDLVYNNLTGP----IPSSLGNLKNLQYLFLYQNKLSG----PIPPSIFSLQKLISLDLSDNSLSG  298 (968)
T ss_pred             -CChhHhcCCCCCEEECcCceeccc----cChhHhCCCCCCEEECcCCeeec----cCchhHhhccCcCEEECcCCeecc
Confidence             233344556666777766666543    34445555666666666666642    234445556666666666666543


Q ss_pred             hhHHHHHHHhcCCCCccEEEccCCCCChhHHHHHHHhhccCCCCceEEEccCCCCCchhHHHHHHHHHcCCCccEEEccC
Q 006842          317 LGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYM  396 (629)
Q Consensus       317 ~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~  396 (629)
                      ..    +..+.++++|++|++++|.++......+     ..+++|+.|++++|.++..    ++..+..+++|+.|++++
T Consensus       299 ~~----p~~~~~l~~L~~L~l~~n~~~~~~~~~~-----~~l~~L~~L~L~~n~l~~~----~p~~l~~~~~L~~L~Ls~  365 (968)
T PLN00113        299 EI----PELVIQLQNLEILHLFSNNFTGKIPVAL-----TSLPRLQVLQLWSNKFSGE----IPKNLGKHNNLTVLDLST  365 (968)
T ss_pred             CC----ChhHcCCCCCcEEECCCCccCCcCChhH-----hcCCCCCEEECcCCCCcCc----CChHHhCCCCCcEEECCC
Confidence            22    2344556666666666666654322222     2344566666666666543    455555666666666666


Q ss_pred             CCCChHHHHHHHHHHhcCCCccEEEeeCCCCCHHHHHHHHHHhhcCCcccEEECcCCCCChhHHHHHHHHHhcCCCccEE
Q 006842          397 NDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTL  476 (629)
Q Consensus       397 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L  476 (629)
                      |.+...    ++..+..+++|+.|++++|.+...    ++..+..+++|+.|++++|.++...+..    +..++.|+.|
T Consensus       366 n~l~~~----~p~~~~~~~~L~~L~l~~n~l~~~----~p~~~~~~~~L~~L~L~~n~l~~~~p~~----~~~l~~L~~L  433 (968)
T PLN00113        366 NNLTGE----IPEGLCSSGNLFKLILFSNSLEGE----IPKSLGACRSLRRVRLQDNSFSGELPSE----FTKLPLVYFL  433 (968)
T ss_pred             CeeEee----CChhHhCcCCCCEEECcCCEeccc----CCHHHhCCCCCCEEECcCCEeeeECChh----HhcCCCCCEE
Confidence            655543    333344444455555555544433    2333344455555555555554332222    2223445555


Q ss_pred             eccCCCCCHHHHHHHHHH-------------------HhcCCCcCEEEcccCCCCccccccCCCchhhhHHHHhhhhhhh
Q 006842          477 KLGWCQIGASGAEFVADM-------------------LRYNNTISILDLRANGLRDEVCSGCNGLSFFHSAIYSLKHMLF  537 (629)
Q Consensus       477 ~L~~n~i~~~~~~~l~~~-------------------l~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~~~~~~~l~~L~~  537 (629)
                      ++++|.++...+..+..+                   ....++|+.|++++|++.+.          .|..+.++++|+.
T Consensus       434 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~----------~~~~~~~l~~L~~  503 (968)
T PLN00113        434 DISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGA----------VPRKLGSLSELMQ  503 (968)
T ss_pred             ECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCc----------cChhhhhhhccCE
Confidence            555554443322222111                   00113445555555555444          5667777888888


Q ss_pred             hhhhhhcchhhHHHHHHHhhhhcccceeecCCCCCCchhHHHHHHHHhcCCccceeeeeccCCccchhHHHHHHHHHHH-
Q 006842          538 YSLCINYLQGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDL-  616 (629)
Q Consensus       538 L~Ls~N~l~~~~~l~~~~~~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~~L~~L~L~~N~i~~~~~~~l~~~~~l-  616 (629)
                      |++++|++++.  ++..+... ++|++|+|++|.+++..|..+..+      ++|+.|+|++|++++..|..+..+..+ 
T Consensus       504 L~Ls~N~l~~~--~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~~~~p~~l~~l~~L~  574 (968)
T PLN00113        504 LKLSENKLSGE--IPDELSSC-KKLVSLDLSHNQLSGQIPASFSEM------PVLSQLDLSQNQLSGEIPKNLGNVESLV  574 (968)
T ss_pred             EECcCCcceee--CChHHcCc-cCCCEEECCCCcccccCChhHhCc------ccCCEEECCCCcccccCChhHhcCcccC
Confidence            88888887765  33334333 678888888888887777777655      468888888888887777777665443 


Q ss_pred             hhhccceE
Q 006842          617 VYEMSEKE  624 (629)
Q Consensus       617 ~~~l~~~~  624 (629)
                      ..++++|.
T Consensus       575 ~l~ls~N~  582 (968)
T PLN00113        575 QVNISHNH  582 (968)
T ss_pred             EEeccCCc
Confidence            23444443

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG4308 consensus LRR-containing protein [Function unknown] Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>KOG4308 consensus LRR-containing protein [Function unknown] Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG4242 consensus Predicted myosin-I-binding protein [Cell motility] Back     alignment and domain information
>KOG4242 consensus Predicted myosin-I-binding protein [Cell motility] Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>KOG3735 consensus Tropomodulin and leiomodulin [Cytoskeleton] Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type Back     alignment and domain information
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type Back     alignment and domain information
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A Back     alignment and domain information
>KOG3735 consensus Tropomodulin and leiomodulin [Cytoskeleton] Back     alignment and domain information
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily Back     alignment and domain information
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>KOG0473 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily Back     alignment and domain information
>smart00370 LRR Leucine-rich repeats, outliers Back     alignment and domain information
>KOG3763 consensus mRNA export factor TAP/MEX67 [RNA processing and modification] Back     alignment and domain information
>KOG3763 consensus mRNA export factor TAP/MEX67 [RNA processing and modification] Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

Original result of BLAST against Protein Data Bank

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query629
2bnh_A457 Porcine Ribonuclease Inhibitor Length = 457 1e-25
2bnh_A457 Porcine Ribonuclease Inhibitor Length = 457 9e-22
3tsr_E457 X-Ray Structure Of Mouse Ribonuclease Inhibitor Com 3e-25
1a4y_A460 Ribonuclease Inhibitor-Angiogenin Complex Length = 3e-20
1z7x_W461 X-Ray Structure Of Human Ribonuclease Inhibitor Com 3e-20
3un9_A372 Crystal Structure Of An Immune Receptor Length = 37 9e-06
1yrg_A385 The Crystal Structure Of Rna1p: A New Fold For A Gt 2e-05
1k5d_C386 Crystal Structure Of Ran-Gppnhp-Ranbp1-Rangap Compl 2e-05
>pdb|2BNH|A Chain A, Porcine Ribonuclease Inhibitor Length = 457 Back     alignment and structure 
Iteration: 1

 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 96/372 (25%), Positives = 172/372 (46%), Gaps = 8/372 (2%)
Query: 150 SKQTLNEFAKELRA---FSSVDMSGRNFGDEGLFFLAESLGYNQTA-EEVSFAANGITAA 205
           +++   +    LRA    + + +     GD G+  + + L       +++S     +T A
Sbjct: 37  TEEHCKDIGSALRANPSLTELCLRTNELGDAGVHLVLQGLQSPTCKIQKLSLQNCSLTEA 96
Query: 206 GIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVD-NAGVERLQLSSVDLRDEGAK 264
           G       L+S   L+ L+LS NP+GD G++ LC+ L+D    +E+LQL    L     +
Sbjct: 97  GCGVLPSTLRSLPTLRELHLSDNPLGDAGLRLLCEGLLDPQCHLEKLQLEYCRLTAASCE 156
Query: 265 AIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENST-IRSLHXXXXXXXXXXXXXXX 323
            +A +L+    L+ L ++NN I  +G   L + L +++  + +L                
Sbjct: 157 PLASVLRATRALKELTVSNNDIGEAGARVLGQGLADSACQLETLRLENCGLTPANCKDLC 216
Query: 324 XXXXXXKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYI 383
                  SLREL L  N +GD GI  L  GL S   +L  L +    I+A G   +   +
Sbjct: 217 GIVASQASLRELDLGSNGLGDAGIAELCPGLLSPASRLKTLWLWECDITASGCRDLCRVL 276
Query: 384 KNCKSLLWINLYMNDIGDEGAEKIADALKQ-NRTITTIDLGGNNIHSKGASAIARVLKDN 442
           +  ++L  ++L  N +GDEGA  + ++L Q    + ++ +   ++ +     ++ +L  N
Sbjct: 277 QAKETLKELSLAGNKLGDEGARLLCESLLQPGCQLESLWVKSCSLTAACCQHVSLMLTQN 336
Query: 443 SVITSLDLAYNPIGADGAKALSEVLKFHG-NINTLKLGWCQIGASGAEFVADMLRYNNTI 501
             +  L L+ N +G  G + L + L   G  +  L LG C++  SG   +A +L  N ++
Sbjct: 337 KHLLELQLSSNKLGDSGIQELCQALSQPGTTLRVLCLGDCEVTNSGCSSLASLLLANRSL 396
Query: 502 SILDLRANGLRD 513
             LDL  N + D
Sbjct: 397 RELDLSNNCVGD 408
>pdb|2BNH|A Chain A, Porcine Ribonuclease Inhibitor Length = 457 Back     alignment and structure
>pdb|3TSR|E Chain E, X-Ray Structure Of Mouse Ribonuclease Inhibitor Complexed With Mouse Ribonuclease 1 Length = 457 Back     alignment and structure
>pdb|1A4Y|A Chain A, Ribonuclease Inhibitor-Angiogenin Complex Length = 460 Back     alignment and structure
>pdb|1Z7X|W Chain W, X-Ray Structure Of Human Ribonuclease Inhibitor Complexed With Ribonuclease I Length = 461 Back     alignment and structure
>pdb|3UN9|A Chain A, Crystal Structure Of An Immune Receptor Length = 372 Back     alignment and structure
>pdb|1YRG|A Chain A, The Crystal Structure Of Rna1p: A New Fold For A Gtpase- Activating Protein Length = 385 Back     alignment and structure
>pdb|1K5D|C Chain C, Crystal Structure Of Ran-Gppnhp-Ranbp1-Rangap Complex Length = 386 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

Original result of RPS-BLAST against PDB70 database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query629
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 1e-118
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 1e-100
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 6e-93
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 2e-89
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 6e-76
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 3e-67
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 1e-40
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 2e-32
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 3e-80
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 2e-76
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 7e-76
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 6e-73
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 2e-63
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 5e-50
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 4e-32
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 2e-67
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 4e-67
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 9e-53
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 6e-33
3un9_A 372 NLR family member X1; leucine rich repeat (LRR), a 3e-21
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 7e-38
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 2e-36
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 9e-35
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 2e-34
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 1e-30
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 4e-29
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 8e-18
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 4e-31
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 7e-30
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 1e-26
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 5e-24
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 1e-22
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 6e-22
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 7e-17
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 1e-13
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 9e-09
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 6e-22
3ogk_B 592 Coronatine-insensitive protein 1; leucine rich rep 1e-16
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 4e-14
3ogk_B 592 Coronatine-insensitive protein 1; leucine rich rep 1e-10
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 3e-21
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 8e-16
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 6e-13
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 3e-12
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 1e-11
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 8e-10
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 1e-09
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 1e-20
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 3e-19
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 5e-18
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 1e-10
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 1e-06
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 4e-19
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 1e-17
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 8e-17
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 1e-15
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 4e-15
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 4e-14
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 5e-11
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 2e-05
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 1e-18
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 4e-17
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 1e-16
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 2e-13
2p1m_B 594 Transport inhibitor response 1 protein; F-BOX, leu 2e-11
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 6e-18
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 9e-16
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 2e-15
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 5e-14
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 6e-13
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 7e-10
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 1e-09
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 3e-16
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 9e-15
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 1e-11
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 1e-11
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 7e-11
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 6e-04
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 1e-15
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 6e-13
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 1e-12
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 1e-11
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 1e-11
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 5e-15
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 2e-13
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 7e-13
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 2e-12
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 5e-12
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 4e-11
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 5e-15
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 3e-12
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 1e-11
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 6e-09
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 5e-15
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 1e-13
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 1e-14
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 2e-09
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 1e-07
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 1e-05
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 4e-14
4ecn_A 876 Leucine-rich repeat protein; leucine-rich repeats, 7e-12
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 3e-10
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 5e-14
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 1e-13
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 3e-13
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 4e-11
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 9e-11
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 4e-10
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 6e-08
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 1e-12
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 6e-12
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 1e-11
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 2e-11
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 5e-11
3o6n_A 390 APL1; leucine-rich repeat, protein binding; HET: N 2e-10
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 5e-04
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 5e-12
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 1e-11
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 3e-11
4ezg_A197 Putative uncharacterized protein; internalin-A, le 8e-12
4ezg_A197 Putative uncharacterized protein; internalin-A, le 1e-08
4ezg_A197 Putative uncharacterized protein; internalin-A, le 7e-07
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 9e-12
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 1e-11
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 6e-11
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 3e-06
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 1e-11
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 6e-09
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 3e-04
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 7e-04
4fmz_A347 Internalin; leucine rich repeat, structural genomi 2e-11
4fmz_A347 Internalin; leucine rich repeat, structural genomi 2e-10
4fmz_A347 Internalin; leucine rich repeat, structural genomi 1e-06
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 2e-11
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 1e-09
3v47_A 455 TOLL-like receptor 5B and variable lymphocyte REC 7e-08
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 6e-07
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 3e-11
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 5e-10
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 5e-06
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 5e-05
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 3e-11
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 2e-09
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 4e-04
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 2e-10
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 1e-08
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 1e-07
1o6v_A466 Internalin A; bacterial infection, extracellular r 2e-10
1o6v_A466 Internalin A; bacterial infection, extracellular r 7e-09
1o6v_A 466 Internalin A; bacterial infection, extracellular r 1e-08
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 2e-10
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 1e-08
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 6e-10
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 5e-09
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 5e-04
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 7e-10
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 1e-05
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 2e-05
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 1e-09
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 5e-06
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 2e-09
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 3e-09
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 7e-04
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 3e-09
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 8e-09
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 2e-07
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 4e-09
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 9e-09
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 3e-04
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 2e-08
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 1e-05
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 2e-05
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 2e-08
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 9e-08
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 4e-06
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 7e-05
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 1e-04
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 6e-08
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 6e-04
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 8e-04
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 8e-08
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 3e-06
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 1e-07
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 2e-07
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 1e-06
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 5e-06
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 1e-05
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 2e-05
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 6e-05
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 1e-07
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 6e-06
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 1e-07
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 4e-06
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 1e-07
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 6e-04
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 2e-07
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 6e-06
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 8e-04
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 6e-07
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 5e-05
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 8e-07
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 2e-04
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 1e-06
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 1e-05
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 1e-05
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 4e-05
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 2e-05
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 1e-04
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 5e-04
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 2e-04
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 3e-04
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 6e-04
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 8e-04
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
 Score =  360 bits (926), Expect = e-118
 Identities = 109/452 (24%), Positives = 180/452 (39%), Gaps = 41/452 (9%)

Query: 166 SVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNL 225
           S+D+      D      AE L   Q  + V     G+T A  K     L+ N AL  LNL
Sbjct: 7   SLDIQCEELSDARW---AELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 226 SGNPIGDEGVKCLCDIL-VDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNN 284
             N +GD GV C+   L   +  +++L L +  L   G   ++  L+    L+ L L++N
Sbjct: 64  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123

Query: 285 MIDYSGFTSLAEALLE-NSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIG 343
           ++  +G   L E LL+    +  L L      A     LA  L      +EL +  N I 
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183

Query: 344 DEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEG 403
           + G+R L  GL     +L  L + +  +++     +   + +  SL  + L  N +GD G
Sbjct: 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243

Query: 404 AEKIADALKQ-NRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKA 462
             ++   L   +  + T+ +    I +KG   + RVL+    +  L LA N +G +GA+ 
Sbjct: 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303

Query: 463 LSEVLKF-HGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEVCSGCNG 521
           L E L      + +L +  C   A+     + +L  N  +  L +  N L D        
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA------- 356

Query: 522 LSFFHSAIYSLKHMLFYSLCINYLQGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIA 581
                                    G + L Q        L  + LA  ++ D    ++A
Sbjct: 357 -------------------------GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA 391

Query: 582 QALKANEDVAVTSLNLANNFLTKFGQSALTDA 613
             L AN   ++  L+L+NN L   G   L ++
Sbjct: 392 ATLLANH--SLRELDLSNNCLGDAGILQLVES 421
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure

Structure Templates Detected by HHsearch ?

Original result of HHsearch against PDB70 database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query629
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 100.0
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 100.0
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 100.0
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 100.0
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 100.0
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 100.0
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 100.0
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 100.0
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 100.0
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.97
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.97
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.97
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.97
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.97
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.97
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.97
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.97
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.97
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.97
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.97
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.97
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.97
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.97
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 99.97
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.97
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.97
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 99.96
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.96
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.96
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.96
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.96
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 99.96
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.96
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.96
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.96
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.96
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 99.96
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.96
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.95
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.95
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.95
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.94
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.94
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.94
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.94
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.93
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.93
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.92
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.91
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.91
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.9
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.9
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.9
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.89
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.89
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.89
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 99.88
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 99.88
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.87
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.87
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.87
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.86
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.86
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.86
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.86
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.86
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.86
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.85
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.84
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.84
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.83
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.83
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.83
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.83
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.83
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.82
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.82
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.82
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.82
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 99.81
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 99.81
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.8
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.76
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.76
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.76
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.74
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 99.74
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.74
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.73
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.73
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 99.72
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.71
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.71
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.7
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 99.63
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.63
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.63
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 99.63
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.62
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.62
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.62
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 99.62
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.61
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 99.59
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.59
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.58
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.55
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.54
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.51
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.49
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.49
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.48
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.48
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.48
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.46
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.46
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.45
4b8c_D 727 Glucose-repressible alcohol dehydrogenase transcr 99.4
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.4
4b8c_D 727 Glucose-repressible alcohol dehydrogenase transcr 99.39
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.39
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 99.39
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.39
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 99.39
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.37
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.37
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.37
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.35
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.34
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.34
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 99.3
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.29
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.29
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.26
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.26
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 99.26
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.22
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.18
1w8a_A192 SLIT protein; signaling protein, secreted protein, 99.18
1w8a_A192 SLIT protein; signaling protein, secreted protein, 99.1
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 99.08
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 99.08
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 99.06
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 99.03
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 98.86
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.84
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 98.79
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.79
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 98.78
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 98.76
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.7
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.67
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 98.43
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 98.36
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 98.28
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 98.27
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 98.21
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 97.87
4gt6_A394 Cell surface protein; leucine rich repeats, putati 97.87
4gt6_A394 Cell surface protein; leucine rich repeats, putati 97.74
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 93.38
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 92.65
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 91.97
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 91.81
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
Probab=100.00  E-value=1.6e-45  Score=394.85  Aligned_cols=445  Identities=23%  Similarity=0.322  Sum_probs=387.6

Q ss_pred             cCCccEEEccCCCCCHHHHHHHHHHhccCCCccEEEeccCCCCHHHHHHHHHHhhcCCCcCEEEccCCCCChhHHHHHHH
Q 006842          161 LRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCD  240 (629)
Q Consensus       161 ~~~L~~L~Ls~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~  240 (629)
                      .+++++|+|+++.+++.....   .+..+++|++|+|++|.+++.+...++..+..+++|++|+|++|.+++.++..+..
T Consensus         2 ~~~l~~L~Ls~~~l~~~~~~~---~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~   78 (461)
T 1z7x_W            2 SLDIQSLDIQCEELSDARWAE---LLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQ   78 (461)
T ss_dssp             CEEEEEEEEESCCCCHHHHHH---HHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred             CccceehhhhhcccCchhHHH---HHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHH
Confidence            357899999999999887544   34456899999999999999999999999999999999999999999888777776


Q ss_pred             HHhhCC-CCCEEEeeccCCChHHHHHHHHHHhcCCCccEEEeccCCCChhhHHHHHHHHhh-cCCccEEeccCCCCChhh
Q 006842          241 ILVDNA-GVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLE-NSTIRSLHLNGNYGGALG  318 (629)
Q Consensus       241 ~l~~~~-~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~-~~~L~~L~L~~n~i~~~~  318 (629)
                      .+.... +|++|+|++|.+++.++..++..+..+++|++|++++|.+++.+...+...+.. .++|++|++++|.++..+
T Consensus        79 ~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~  158 (461)
T 1z7x_W           79 GLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS  158 (461)
T ss_dssp             TTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred             HHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHH
Confidence            654332 799999999999999999999999999999999999999998888888877654 568999999999999999


Q ss_pred             HHHHHHHhcCCCCccEEEccCCCCChhHHHHHHHhhccCCCCceEEEccCCCCCchhHHHHHHHHHcCCCccEEEccCCC
Q 006842          319 ANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMND  398 (629)
Q Consensus       319 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~  398 (629)
                      ...++..+..+++|++|++++|.+++.++..+...+....++|++|++++|.+++.+...++..+..+++|++|++++|.
T Consensus       159 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~  238 (461)
T 1z7x_W          159 CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK  238 (461)
T ss_dssp             HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSB
T ss_pred             HHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCc
Confidence            88999999999999999999999999999889888876777899999999999999988899999999999999999999


Q ss_pred             CChHHHHHHHHHHh-cCCCccEEEeeCCCCCHHHHHHHHHHhhcCCcccEEECcCCCCChhHHHHHHHHHhcC-CCccEE
Q 006842          399 IGDEGAEKIADALK-QNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFH-GNINTL  476 (629)
Q Consensus       399 l~~~~~~~l~~~l~-~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~-~~L~~L  476 (629)
                      +++.++..++..+. .+++|++|++++|.+++.+...++..+..+++|++|++++|.+++.+...+...+... ++|++|
T Consensus       239 l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L  318 (461)
T 1z7x_W          239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL  318 (461)
T ss_dssp             CHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEE
T ss_pred             CChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceee
Confidence            99998888877765 4789999999999999999999999999999999999999999999998888877654 599999


Q ss_pred             eccCCCCCHHHHHHHHHHHhcCCCcCEEEcccCCCCccccccCCCchhhhHHHHh-----hhhhhhhhhhhhcchh--hH
Q 006842          477 KLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEVCSGCNGLSFFHSAIYS-----LKHMLFYSLCINYLQG--AK  549 (629)
Q Consensus       477 ~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~~~~~~~-----l~~L~~L~Ls~N~l~~--~~  549 (629)
                      ++++|.++..+...+...+..+++|++|++++|.+++.          .+..+..     .++|+.|++++|.+++  ..
T Consensus       319 ~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~----------~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~  388 (461)
T 1z7x_W          319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA----------GVRELCQGLGQPGSVLRVLWLADCDVSDSSCS  388 (461)
T ss_dssp             ECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHH----------HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHH
T ss_pred             EcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccc----------cHHHHHHHHcCCCCceEEEECCCCCCChhhHH
Confidence            99999999999999999999999999999999999876          3344433     5699999999999984  33


Q ss_pred             HHHHHHhhhhcccceeecCCCCCCchhHHHHHHHHhcCCccceeeeeccCCccchhHHHHHHHHHHHhhhc
Q 006842          550 CLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEM  620 (629)
Q Consensus       550 ~l~~~~~~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~~L~~L~L~~N~i~~~~~~~l~~~~~l~~~l  620 (629)
                      .++..+.. +++|++||+++|+|++.+...+.+.+++.. .+|+.|++.++.+.....+.+..+.....++
T Consensus       389 ~l~~~l~~-~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~-~~L~~L~~~~~~~~~~~~~~l~~l~~~~p~l  457 (461)
T 1z7x_W          389 SLAATLLA-NHSLRELDLSNNCLGDAGILQLVESVRQPG-CLLEQLVLYDIYWSEEMEDRLQALEKDKPSL  457 (461)
T ss_dssp             HHHHHHHH-CCCCCEEECCSSSCCHHHHHHHHHHHTSTT-CCCCEEECTTCCCCHHHHHHHHHHHHHCTTS
T ss_pred             HHHHHHHh-CCCccEEECCCCCCCHHHHHHHHHHhccCC-cchhheeecccccCHHHHHHHHHHhccCCCc
Confidence            45666654 489999999999999999999998887433 4799999999999988877777766655444
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

Original result of RPS-BLAST against SCOP70(version1.75) database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 629
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 3e-22
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 7e-18
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 8e-18
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 2e-17
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 1e-16
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 2e-16
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 3e-16
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 5e-16
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 7e-16
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 3e-15
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 1e-14
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 3e-14
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 3e-12
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 8e-11
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 2e-10
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 2e-09
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 2e-06
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 0.001
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 0.004
d2ca6a1344 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom 9e-20
d2ca6a1344 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom 8e-19
d2ca6a1344 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom 1e-18
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 2e-14
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 3e-13
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 5e-13
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 7e-12
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 3e-09
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 4e-08
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 6e-06
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 4e-13
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 7e-12
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 4e-11
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 3e-09
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 1e-08
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 1e-06
d2astb2284 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 0.001
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 0.003
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.7 bits (241), Expect = 3e-22
 Identities = 104/455 (22%), Positives = 177/455 (38%), Gaps = 16/455 (3%)

Query: 166 SVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNL 225
           S+D+      D     L   L   Q    V     G+T A  K     L+ N AL  LNL
Sbjct: 6   SLDIQCEELSDARWAELLPLLQQCQV---VRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 226 SGNPIGDEGVKCLCDIL-VDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNN 284
             N +GD GV C+   L   +  +++L L +  L   G   ++  L+    L+ L L++N
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122

Query: 285 MIDYSGFTSLAEALLENSTI-RSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIG 343
           ++  +G   L E LL+       L L      A     LA  L      +EL +  N I 
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 182

Query: 344 DEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEG 403
           + G+R L  GL     +L  L + +  +++     +   + +  SL  + L  N +GD G
Sbjct: 183 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242

Query: 404 AE-KIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKA 462
                   L  +  + T+ +    I +KG   + RVL+    +  L LA N +G +GA+ 
Sbjct: 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302

Query: 463 LSEVLKFHGNINTL-KLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEVCSGCNG 521
           L E L   G       +  C   A+     + +L  N  +  L +  N L D        
Sbjct: 303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362

Query: 522 LSFFHSAIYSLKHMLFYSLCINYL--QGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFA 579
                     L+ +    L    +       LA +    N +L  +DL+ N + D G   
Sbjct: 363 GLGQP--GSVLRVL---WLADCDVSDSSCSSLAATLL-ANHSLRELDLSNNCLGDAGILQ 416

Query: 580 IAQALKANEDVAVTSLNLANNFLTKFGQSALTDAK 614
           + ++++      +  L L + + ++  +  L   +
Sbjct: 417 LVESVRQP-GCLLEQLVLYDIYWSEEMEDRLQALE 450
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

Original result of HHsearch against SCOP70(version1.75) database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query629
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 100.0
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 100.0
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 99.96
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 99.96
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.89
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.85
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.76
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.76
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.76
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.74
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.74
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.73
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.72
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.69
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.68
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.63
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.59
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.57
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.55
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 99.54
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.53
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.51
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 99.51
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.49
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 99.49
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 99.48
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.48
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.47
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 99.29
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 99.28
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.26
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.22
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.22
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.19
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.17
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.16
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 99.14
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 98.94
d2ifga3156 High affinity nerve growth factor receptor, N-term 98.47
d2ifga3156 High affinity nerve growth factor receptor, N-term 98.47
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 98.39
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 98.37
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-37  Score=326.18  Aligned_cols=449  Identities=23%  Similarity=0.326  Sum_probs=377.1

Q ss_pred             CCccEEEccCCCCCHHHHHHHHHHhccCCCccEEEeccCCCCHHHHHHHHHHhhcCCCcCEEEccCCCCChhHHHHHHHH
Q 006842          162 RAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDI  241 (629)
Q Consensus       162 ~~L~~L~Ls~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~  241 (629)
                      .+|++||++++++++.++..+...   ++++++|+|++|+|++.++..++.++..+++|++|||++|.|++.++..++..
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~---l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~   78 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPL---LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG   78 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHH---HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHT
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHh---CCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHH
Confidence            358999999999999886665544   48889999999999999999999999999999999999999999998888887


Q ss_pred             Hhh-CCCCCEEEeeccCCChHHHHHHHHHHhcCCCccEEEeccCCCChhhHHHHHHHHhh-cCCccEEeccCCCCChhhH
Q 006842          242 LVD-NAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLE-NSTIRSLHLNGNYGGALGA  319 (629)
Q Consensus       242 l~~-~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~-~~~L~~L~L~~n~i~~~~~  319 (629)
                      +.. ..+|++|+|++|++++.+...++..+..+++|++|++++|.|++.++..+...+.. .............+...+.
T Consensus        79 l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~  158 (460)
T d1z7xw1          79 LQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC  158 (460)
T ss_dssp             TCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH
T ss_pred             HhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhh
Confidence            765 45799999999999999999999999999999999999999998888888777654 3455666777777777777


Q ss_pred             HHHHHHhcCCCCccEEEccCCCCChhHHHHHHHhhccCCCCceEEEccCCCCCchhHHHHHHHHHcCCCccEEEccCCCC
Q 006842          320 NALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDI  399 (629)
Q Consensus       320 ~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l  399 (629)
                      ..+...+.....++.++++++.+.+.++..+...+.........+++..+.+...++......+...+.++.+++++|.+
T Consensus       159 ~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~  238 (460)
T d1z7xw1         159 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL  238 (460)
T ss_dssp             HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBC
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccc
Confidence            77778888889999999999999888888777777666667889999999998888888888888999999999999998


Q ss_pred             ChHHHHHHHHH-HhcCCCccEEEeeCCCCCHHHHHHHHHHhhcCCcccEEECcCCCCChhHHHHHHHHHhc-CCCccEEe
Q 006842          400 GDEGAEKIADA-LKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKF-HGNINTLK  477 (629)
Q Consensus       400 ~~~~~~~l~~~-l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~-~~~L~~L~  477 (629)
                      .+.++...... ......++.+++++|.+.......+...+..++.++.+++++|.+++.+...+...+.. ...|+.++
T Consensus       239 ~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~  318 (460)
T d1z7xw1         239 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW  318 (460)
T ss_dssp             HHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred             cccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccc
Confidence            88766544443 33467899999999999998888888888889999999999999999999888877654 46899999


Q ss_pred             ccCCCCCHHHHHHHHHHHhcCCCcCEEEcccCCCCccccccCCCchhhhHHHH-hhhhhhhhhhhhhcchh--hHHHHHH
Q 006842          478 LGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEVCSGCNGLSFFHSAIY-SLKHMLFYSLCINYLQG--AKCLAQS  554 (629)
Q Consensus       478 L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~~~~~~~-~l~~L~~L~Ls~N~l~~--~~~l~~~  554 (629)
                      +++|.++..+...+..++..+++|++|+|++|+|++.      ++..+...+. ..+.|++|+|++|.|+.  +..++..
T Consensus       319 l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~------g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~  392 (460)
T d1z7xw1         319 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA------GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT  392 (460)
T ss_dssp             CTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHH------HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred             ccccchhhhhhhhcccccccccchhhhheeeecccCc------ccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHH
Confidence            9999999999999999988999999999999999765      1222333343 35679999999999974  4556666


Q ss_pred             HhhhhcccceeecCCCCCCchhHHHHHHHHhcCCccceeeeeccCCccchhHHHHHHHHHHHhhhcc
Q 006842          555 FKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMS  621 (629)
Q Consensus       555 ~~~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~~L~~L~L~~N~i~~~~~~~l~~~~~l~~~l~  621 (629)
                      +... ++|++|||++|+|++.+...+.+.++.+. ..|+.|++.+|.+.+.....+..+.+...++.
T Consensus       393 l~~~-~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~-~~L~~l~l~~~~~~~~~~~~l~~l~~~~~~l~  457 (460)
T d1z7xw1         393 LLAN-HSLRELDLSNNCLGDAGILQLVESVRQPG-CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLR  457 (460)
T ss_dssp             HHHC-CCCCEEECCSSSCCHHHHHHHHHHHTSTT-CCCCEEECTTCCCCHHHHHHHHHHHHHCTTSE
T ss_pred             HhcC-CCCCEEECCCCcCCHHHHHHHHHHHHhCC-CccCEEECCCCCCCHHHHHHHHHHHHhCCCCE
Confidence            6544 89999999999999999999999987655 47999999999999999988877776655543
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure